Advertisement

Reactions Weekly

, Volume 1723, Issue 1, pp 138–138 | Cite as

Erlotinib

Development of drug resistance in metastatic lung adenocarcinoma: case report
Case report
  • 17 Downloads

Reference

  1. Theoleyre S, et al. Treatment of a NSCLC patient with osimertinib based on the detection of the EGFR T790M resistance mutation in cerebrospinal fluid. Lung Cancer 114: 111-112, Dec 2017. Available from: URL: http://doi.org/10.1016/j.lungcan.2017.10.010 - France

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations